Skip to content

Dr. Barry Dworkin

  • About
  • Radio Interviews
    • Wednesday House Call
    • Sunday House Call Shows
  • Articles
    • Health Headlines
    • Prevention and Screening
    • Clinical Research
    • Health Policy
    • Cancer/Oncology
    • Neurology
  • Lancet posts Oxford Vaccine Group preprint study on how the timing of the booster dose of its Oxford-AZ vaccine affects the immune response and efficacy for people 18-55 years of age.

    February 4, 2021

    Medical Mythbusting Commentary for February 4, 2021 Source:U.K. says new study vindicates delaying 2nd AstraZeneca shot Reference:Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

  • Facebook
  • X

Notifications